##  [Mexico's Regulation: COFEPRIS Eliminates the Review of Notices as Part of Administrative Simplification - Drugs](/index%2ephp/mandate/mexicos-regulation-cofepris-eliminates-the-review-of-notices-as-part-of-administrative-simplification-drugs) 

March 12, 2026

The document outlines the removal of review requirements for self-managed Notices submitted to COFEPRIS, outlines continued regulatory oversight, specifies exceptions, and highlights the move toward digital transformation.

**This document covers the following information:**

- Elimination of express review and approval for most Notices submitted to COFEPRIS
- Clarification that Notices are now considered self-managed procedures
- Equal legal validity for physical and electronic submissions through corresponding acknowledgments of receipt
- Continued responsibility for regulated entities to comply with all relevant health regulations
- Ongoing verification, surveillance, and sanitary control actions by COFEPRIS after submission
- Potential for sanctions and security measures if irregularities or inconsistencies are found in submitted information
- Exceptions for specific import and export Notices, which will continue to require review until technical adjustments are implemented
- Collaboration with the Digital Transformation and Telecommunications Agency to promote good regulatory practices and reduce bureaucracy without compromising public health



[Consult Now](/webform/consult%0A?url=https://preprod.freyrsolutions.com/index%2ephp/markdownify/node/12998)



Source

[https://www.gob.mx/cofepris/es/articulos/cofepris-elimina-dictaminacion-de-avis…](https://www.gob.mx/cofepris/es/articulos/cofepris-elimina-dictaminacion-de-avisos-como-parte-de-la-simplificacion-administrativa?idiom=es)

 

 

Select Mandate HA

[COFEPRIS](/index%2ephp/mandate-by-ha/cofepris)

 

Select Mandate Function

[Country Regulatory Affairs](/index%2ephp/mandate-by-function/country-regulatory-affairs)